1. Home
  2. SNT vs SER Comparison

SNT vs SER Comparison

Compare SNT & SER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Senstar Technologies Ltd.

SNT

Senstar Technologies Ltd.

HOLD

Current Price

$1.61

Market Cap

64.6M

ML Signal

HOLD

Logo Serina Therapeutics Inc.

SER

Serina Therapeutics Inc.

HOLD

Current Price

$2.30

Market Cap

56.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SNT
SER
Founded
1965
2017
Country
Canada
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
64.6M
56.4M
IPO Year
2023
2024

Fundamental Metrics

Financial Performance
Metric
SNT
SER
Price
$1.61
$2.30
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$15.00
AVG Volume (30 Days)
11.2K
49.0K
Earning Date
04-23-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$130,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$19.22
N/A
Revenue Growth
N/A
132.14
52 Week Low
$1.43
$1.22
52 Week High
$5.34
$5.83

Technical Indicators

Market Signals
Indicator
SNT
SER
Relative Strength Index (RSI) 34.30 45.56
Support Level N/A $1.69
Resistance Level $1.89 $2.90
Average True Range (ATR) 0.07 0.23
MACD -0.01 -0.03
Stochastic Oscillator 13.24 38.46

Price Performance

Historical Comparison
SNT
SER

About SNT Senstar Technologies Ltd.

Senstar Technologies Corp is an international provider of comprehensive physical, video, and access control security products and solutions. The company offers comprehensive solutions for critical sites, which leverage its broad portfolio of homegrown PIDS (Perimeter Intrusion Detection Systems), advanced VMS and SMS (Video Management Software and Security Management Software) with native IVA (Intelligent Video Analytics) security solutions, as well as access control products and technologies. Geographically, the company operates in North America, which derives maximum revenue; Europe; APAC; South and Latin America; and Others.

About SER Serina Therapeutics Inc.

Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers. The company has one reportable segment relating to the research and development of its POZ platform. The segment derives its revenues from Grant revenue. Its main product candidate, SER-252 for advanced Parkinson's disease, is anticipated to enter clinical trials.

Share on Social Networks: